Major potential commercial outcomes of the Monash discovery are screening tests for a variety of solid tumors and a range of therapeutic compounds for the treatment of prostate, renal, lung and breast cancers in humans. Potential Market Lung cancer is the leading cause of cancer related deaths in both men and women. The first two are primarily treated with surgery if the tumor has not spread too far. Oat cell is primarily treated with chemotherapy. Radiation therapy is used in both groups of lung malignancies.
Breast cancer is the most common cancer among women, other than skin cancer.
It is the second leading cause of cancer death in women, after lung cancer. Approximately 500,000 new cases of invasive breast cancer are diagnosed in Western populations each year. Prostate cancer is a commonly occurring cancer in males and accounts for the second highest number of cancer related deaths in men. It is estimated that 1 in 11 Caucasian men will develop clinically significant prostate cancer during their lifetime. There is a clear need to develop new therapies for prostate cancer and techniques that will aid in the early diagnosis of prostate cancer.